These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8034993)

  • 1. HBsAg subtypes among HBsAg carriers in Okinawa, Japan. Evidence of an important relationship in seroconversion from HBeAg to anti-HBe.
    Noguchi A; Hayashi J; Nakashima K; Hirata M; Ikematsu H; Kashiwagi S
    J Infect; 1994 Mar; 28(2):141-50. PubMed ID: 8034993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers.
    Shiina S; Fujino H; Uta Y; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y
    Am J Gastroenterol; 1991 Jul; 86(7):866-71. PubMed ID: 2058629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex- and age-specific prevalences of HBeAg and anti-HBe among HBsAg carriers with or without liver function abnormalities in Okinawa, Japan.
    Hayashi J; Kashiwagi S; Ikematsu H; Nomura H; Kajiyama W; Noguchi A; Ikeda K
    Microbiol Immunol; 1988; 32(8):843-50. PubMed ID: 3200170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural seroconversion from hepatitis Be antigen to antibody among hepatitis B virus carriers in Okinawa Islands.
    Sakugawa H; Ohwan T; Yamashiro A; Oyakawa T; Kadena K; Kinjo F; Saito A
    J Med Virol; 1991 Jun; 34(2):122-6. PubMed ID: 1890412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Gastroenterol Jpn; 1990 Oct; 25(5):593-7. PubMed ID: 2227250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection.
    Furusyo N; Hayashi J; Sawayama Y; Kishihara Y; Kashiwagi S
    Am J Trop Med Hyg; 1999 Apr; 60(4):616-22. PubMed ID: 10348237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-specific prevalence of hepatitis B e antigen (HBeAg) and antibody to HBeAg (anti-HBe) among asymptomatic hepatitis B surface antigen (HBsAg) carriers in Okinawa and Kyushu, Japan.
    Kashiwagi S; Hayashi J; Nomura H; Kajiyama W; Ikematsu H; Shingu T; Hayashida K; Kaji M
    Microbiol Immunol; 1986; 30(7):675-82. PubMed ID: 3773791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B surface antigen particles of subtypes adw and adr, and compound subtype (adwr) in symptom-free carriers in Japan.
    Kanagawa H; Takai E; Tsuda F; Machida A; Kojima M; Ishijima A; Tanaka T; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1992 Aug; 37(4):288-93. PubMed ID: 1383415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.
    Chen DS; Lai MY; Lee SC; Yang PM; Sheu JC; Sung JL
    J Med Virol; 1986 May; 19(1):87-94. PubMed ID: 3701304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of hepatitis B e antigen (HBeAg) and anti-HBe in carriers with different levels of HBsAg.
    Nath N; Fang CT; Fields HA; Doto IL; Maynard JE
    J Med Virol; 1980; 6(2):179-84. PubMed ID: 7241093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HBeAg and anti-HBe among HBsAg carrier thai children.
    Pongpipat D; Suvatte V; Assateerawatts A
    J Med Assoc Thai; 1981 Nov; 64(11):562-7. PubMed ID: 7320671
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B e antigen and antibody in asymptomatic Chinese with hepatitis B surface antigenemia in Taiwan.
    Sung JL; Chen DS; Lai MY; Wang TH; Wang CY; Yü JY; Lee CY
    Gastroenterol Jpn; 1982; 17(4):341-6. PubMed ID: 7141198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-HBs-F(ab)'2 to the seroconversion of HBsAg carriers].
    An P
    Zhonghua Yi Xue Za Zhi; 1992 Nov; 72(11):647-50, 701. PubMed ID: 1338699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
    Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
    Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
    Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HBe antigen-antibody system and its relationship to clinical and laboratory findings in 100 chronic HBsAg carriers in Great Britain.
    Viola LA; Barrison IG; Coleman JC; Paradinas FJ; Murray-Lyon IM
    J Med Virol; 1981; 8(3):169-75. PubMed ID: 7328422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The interrelationships of hepatitis B e antigen antibody and HBsAg-circulating immune complexes in asymptomatic HBsAg carriers].
    Chang ML; Chou CT; Lee CF; Chang DM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):224-9. PubMed ID: 3256466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part II: Evaluation of epidemiological factors and suspected risk factors of liver dysfunction.
    Shiina S; Fujino H; Kawabe T; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y
    Am J Gastroenterol; 1991 Jul; 86(7):872-5. PubMed ID: 2058630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.